fr 139317 has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McMurdo, L; Thiemermann, C; Vane, JR | 1 |
| Erikson, JM; Velasco, CE | 1 |
2 other study(ies) available for fr 139317 and Heart Disease, Ischemic
| Article | Year |
|---|---|
The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
Topics: Anesthesia; Animals; Azepines; Blood Pressure; Coronary Circulation; Electrocardiography; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Indoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Vasoconstriction | 1994 |
Endothelin-1 and myocardial preconditioning.
Topics: Animals; Azepines; Coronary Circulation; Dogs; Endothelin Receptor Antagonists; Endothelins; Indoles; Infusions, Intravenous; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Pilot Projects; Protein Kinase C; Random Allocation; Receptors, Endothelin; Sodium Chloride; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |